✦ LIBER ✦

Adopive immunotherapy with interleukin-2 (IL2) + interferon (αIFN) + IL2-activated lymphocytes (LAK) in metastatic renal cell cancer

✍ Scribed by Goey, S.H.; Kruit, W.H.J.; Eggermont, A.M.M.; Bolhuis, R.L.H.; Stoter, G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunotherapy with interleukin-2 and α-i

✍ Meehan, K R; Arun, B; Gehan, E A; Berberian, B; Sulica, V; Areman, E M; Mazumder 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 69 KB

Immunotherapy with interleukin-2 (IL2) a

✍ Escudier, B; Farace, F; Angevin, E; Charpentier, F; Nitenberg, G; Triebel, F; He 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 780 KB

470 Original regimen of subcutaneous int

✍ B. Escudier; J.F. Rossi; A. Ravaud; J. Savary; K. Pignard; S. Négrier 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 163 KB

A phase II study of chronic low dose of

✍ Michele Potenzoni; Luigi Benecchi; Nicoletta Uliano; Federico Cantoni; Matteo Da 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 202 KB

Clinical experience with the combined us

✍ W. H. J. Kruit; S. H. Goey; J. R. T. Monson; R. A. Stahel; F. Calabresi; R. Mert 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

LOW-DOSE INTERLEUKIN-2 (IL-2) IN COMBINA

✍ Kharkevich, G.; Tsimafeyeu, I.; Demidov, L. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 46 KB